BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19307596)

  • 1. Reversion-induced LIM interaction with Src reveals a novel Src inactivation cycle.
    Zhang Y; Tu Y; Zhao J; Chen K; Wu C
    J Cell Biol; 2009 Mar; 184(6):785-92. PubMed ID: 19307596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTPL1/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of Src kinase.
    Glondu-Lassis M; Dromard M; Lacroix-Triki M; Nirdé P; Puech C; Knani D; Chalbos D; Freiss G
    Cancer Res; 2010 Jun; 70(12):5116-26. PubMed ID: 20501847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pro-apoptotic protein Prostate Apoptosis Response Protein-4 (Par-4) can be activated in colon cancer cells by treatment with Src inhibitor and 5-FU.
    Kline CL; Irby RB
    Apoptosis; 2011 Dec; 16(12):1285-94. PubMed ID: 21910008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTPL1/FAP-1 negatively regulates TRIP6 function in lysophosphatidic acid-induced cell migration.
    Lai YJ; Lin WC; Lin FT
    J Biol Chem; 2007 Aug; 282(33):24381-7. PubMed ID: 17591779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Src activation regulates anoikis in human colon tumor cell lines.
    Windham TC; Parikh NU; Siwak DR; Summy JM; McConkey DJ; Kraker AJ; Gallick GE
    Oncogene; 2002 Nov; 21(51):7797-807. PubMed ID: 12420216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of Gab1 and SHP2 in paxillin tyrosine dephosphorylation and Src activation in response to epidermal growth factor.
    Ren Y; Meng S; Mei L; Zhao ZJ; Jove R; Wu J
    J Biol Chem; 2004 Feb; 279(9):8497-505. PubMed ID: 14665621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The unique N-terminal region of SRMS regulates enzymatic activity and phosphorylation of its novel substrate docking protein 1.
    Goel RK; Miah S; Black K; Kalra N; Dai C; Lukong KE
    FEBS J; 2013 Sep; 280(18):4539-59. PubMed ID: 23822091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of STAT3 by the Src family kinase Hck requires a functional SH3 domain.
    Schreiner SJ; Schiavone AP; Smithgall TE
    J Biol Chem; 2002 Nov; 277(47):45680-7. PubMed ID: 12244095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRL3 promotes cell invasion and proliferation by down-regulation of Csk leading to Src activation.
    Liang F; Liang J; Wang WQ; Sun JP; Udho E; Zhang ZY
    J Biol Chem; 2007 Feb; 282(8):5413-9. PubMed ID: 17192274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased CHK protein levels are associated with Src activation in colon cancer cells.
    Zhu S; Bjorge JD; Cheng HC; Fujita DJ
    Oncogene; 2008 Mar; 27(14):2027-34. PubMed ID: 17934522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired resistance to 5-fluorouracil via HSP90/Src-mediated increase in thymidylate synthase expression in colon cancer.
    Ahn JY; Lee JS; Min HY; Lee HY
    Oncotarget; 2015 Oct; 6(32):32622-33. PubMed ID: 26416450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Src kinase by protein-tyrosine phosphatase-PEST in osteoclasts: comparative analysis of the effects of bisphosphonate and protein-tyrosine phosphatase inhibitor on Src activation in vitro.
    Chellaiah MA; Schaller MD
    J Cell Physiol; 2009 Aug; 220(2):382-93. PubMed ID: 19350555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-actinin-1 phosphorylation modulates pressure-induced colon cancer cell adhesion through regulation of focal adhesion kinase-Src interaction.
    Craig DH; Haimovich B; Basson MD
    Am J Physiol Cell Physiol; 2007 Dec; 293(6):C1862-74. PubMed ID: 17898132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of TOPK at Y74, Y272 by Src increases the stability of TOPK and promotes tumorigenesis of colon.
    Xiao J; Duan Q; Wang Z; Yan W; Sun H; Xue P; Fan X; Zeng X; Chen J; Shao C; Zhu F
    Oncotarget; 2016 Apr; 7(17):24483-94. PubMed ID: 27016416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation.
    Darmoul D; Gratio V; Devaud H; Peiretti F; Laburthe M
    Mol Cancer Res; 2004 Sep; 2(9):514-22. PubMed ID: 15383630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of PTP-BL PDZ domains with RIL: an enigmatic role for the RIL LIM domain.
    van den Berk LC; van Ham MA; te Lindert MM; Walma T; Aelen J; Vuister GW; Hendriks WJ
    Mol Biol Rep; 2004 Dec; 31(4):203-15. PubMed ID: 15663004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTP1B contributes to the oncogenic properties of colon cancer cells through Src activation.
    Zhu S; Bjorge JD; Fujita DJ
    Cancer Res; 2007 Nov; 67(21):10129-37. PubMed ID: 17974954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The zyxin-related protein TRIP6 interacts with PDZ motifs in the adaptor protein RIL and the protein tyrosine phosphatase PTP-BL.
    Cuppen E; van Ham M; Wansink DG; de Leeuw A; Wieringa B; Hendriks W
    Eur J Cell Biol; 2000 Apr; 79(4):283-93. PubMed ID: 10826496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Src activity disrupts cadherin/catenin-mediated homotypic adhesion in human colon cancer and transformed rodent cells.
    Irby RB; Yeatman TJ
    Cancer Res; 2002 May; 62(9):2669-74. PubMed ID: 11980666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Src family kinases mediate receptor-stimulated, phosphoinositide 3-kinase-dependent, tyrosine phosphorylation of dual adaptor for phosphotyrosine and 3-phosphoinositides-1 in endothelial and B cell lines.
    Stephens LR; Anderson KE; Hawkins PT
    J Biol Chem; 2001 Nov; 276(46):42767-73. PubMed ID: 11524430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.